Six-minute walk distance and dyspnoea scores to assess the course of COPD exacerbation in elderly patients

Clinical Respiratory Journal

Volumn 7, Issue 3, 2013, Pages 261-267

  Blankenburg, Thomas ^a   Guettel, Anne ^a   Busch, Christian ^a   Schuette, Wolfgang ^a  

^a City Hospital Martha Maria Halle Doelau   (Germany)

Author keywords

6 min walk test; COPD; Dyspnoea score; Exacerbation; Pulmonary function test

Indexed keywords

FENOTEROL; IPRATROPIUM BROMIDE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DYSPNEA; ELDERLY CARE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; VISUAL ANALOG SCALE; WALKING;

6-MIN WALK TEST; COPD; DYSPNOEA SCORE; EXACERBATION; PULMONARY FUNCTION TEST;

ACUTE DISEASE; AGED; DISABILITY EVALUATION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VISUAL ANALOG SCALE; WALKING;

EID: 84880168968     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2012.00314.x     Document Type: Article

References (28)

1. Fabbri LM, Hurd SS. GOLD Scientific Committee: global strategy for the diagnosis, management and prevention of COPD 2003 update. Eur Respir J. 2003;22: 1-2.
2. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1997;10: 815-821.
3. Mahler DA, Donohue JF, Barbee RA, etal. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest. 1999;115: 957-965.
4. Vincken W, van Noord JA, Greefhorst APM, Bantje TA, Kesten S, Korducki L, Cornelissen PJG, on behalf of the Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19: 209-216.
5. Calverley PMA, Anderson JA, Celli M, etal. for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356: 775-789.
6. Martinez FJ, Foster G, Curtis JL, etal. for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173: 1326-1334.
7. Compton CH, Gubb J, Nieman R, etal. for the International Study Group. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet. 2001;358: 265-270.
8. Celli BR, Cote CG, Marin JM, etal. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350: 1005-1012.
9. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117: 398S-401S.
10. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21: 46s-53s.
11. Anthonisen NR, Manfreda J, Warren CP, etal. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106: 196-204.
12. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129: 536-554.
13. Griffiths TL, Burr ML, Campell IA, etal. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355: 362-368.
14. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;58: 1384-1387.
15. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23: 28-33.
16. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J. 1996;9: 431-435.
17. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis. 1986;135: 1129-1134.
18. Spencer S, Calverley PMA, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23: 698-702.
19. Windisch W, Freidel K, Schucher B, etal. Evaluation of health related quality of life using the MOS 36-item short form health status survey in patients receiving noninvasive positive pressure ventilation. Intensive Care Med. 2003;29: 615-621.
20. Celli BR, MacNee W, Agusti A, etal. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23: 932-946.
21. Guyatt GH, Pugsley SO, Sullivan MJ, etal. Effect of encouragement on walking test performance. Thorax. 1984;39: 818-822.
22. Bullinger M, Kirchberger I. SF-36 fragebogen zum gesundheitszustand. Göttingen, Bern, Toronto, Seattle, Hogrefe Verlag für Psychologie, 1998.
23. Carr SJ, Goldstein RS, Brooks D. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest. 2007;132: 127-134.
24. Calverley P, Pauwels R, Lofdahl CG, Svensson K, Higenbottam T, Carlsson LG, Stahl E. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J. 2005;26: 406-413.
25. Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J. 2007;5: 907-913.
26. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26: 420-428.
27. Vogiatzis I, Nanas S, Kastanakis E, Georgiadou O, Papazahou O, Roussos C. Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD. Eur Respir J. 2004;24: 385-390.
28. Blankenburg T, Guettel A, Schaedlich S, Schuette W. Hypercapnic failure in patients with COPD under 4 weeks non-invasive, home mechanical ventilation. Pneumologie. 2007;62: 126-136.